๐ฐ Observational Study News
Page 2 - Observational Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Observational Study. Real-time updates on events, politics, business and more.
April 25, 2024
A soon-to-be presented observational study found that a higher BMI may indicate a lower risk of dying from cardiovascular-related causes. Does that mean that weighing more is okay in later life? Not so fast, say endocrinologists.
April 8, 2024
A new observational study links coffee with reduced risk of colorectal cancer recurrence. However, experts say there is not enough evidence to recommend drinking coffee if you are at risk.
April 8, 2024
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory AnginaSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results
March 25, 2024
The HIPPOCRATES consortium aims to help predict those who will develop the condition, diagnose it earlier, and one day even prevent it.
December 12, 2023
A recent Swiss study, despite having a better methodology than previous research, can do little more than fuel hypotheses.
December 2, 2023
The FDA may consider approval of the cross-sex hormone estradiol for gender incongruence in adults and minors based on an observational study and not an RCT with placebo.
December 1, 2023
โ Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support...
December 1, 2023
โ Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification โโ Analysis of 72 patients treated in STK-001 clinical trials suggests that higher...
November 22, 2023
In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patientโs baseline C-reactive protein (CRP) levels.
November 21, 2023
โ New data include 24-month results from the largest and longest prospective natural history study of children and adolescents with Dravet syndrome, which showed a lack of improvement despite...